HCPCS Level IIdrugActive
J1552
Inj, alyglo, 500 mg
BETOS: O1E
Effective: 2025-01-01
Referenced in 7 policies
Description
Injection, immune globulin (alyglo), 500 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Alyglo
Manufacturer
GC Biopharma USA, Inc.
HCPCS Dosage
500 MG
Billing Units
10.0000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.